Tvardi Therapeutics Files 8-K/A Amendment
Ticker: TVRD · Form: 8-K/A · Filed: May 13, 2025 · CIK: 1346830
| Field | Detail |
|---|---|
| Company | Tvardi Therapeutics, Inc. (TVRD) |
| Form Type | 8-K/A |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, acquisition, financials
TL;DR
Tvardi Therapeutics filed an 8-K/A amendment on April 15, 2025, updating asset acquisition/disposition details and financials.
AI Summary
Tvardi Therapeutics, Inc. filed an amendment (8-K/A) on May 13, 2025, to a previous filing concerning the completion of an acquisition or disposition of assets. The amendment also includes financial statements and exhibits related to this event, which occurred on April 15, 2025. The company was formerly known as Cara Therapeutics, Inc.
Why It Matters
This filing provides updated information and exhibits related to a significant corporate event, potentially impacting investors' understanding of the company's asset structure and financial position.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing, primarily providing updated documentation rather than announcing new material events.
Key Players & Entities
- Tvardi Therapeutics, Inc. (company) — Registrant
- Cara Therapeutics, Inc. (company) — Former company name
- April 15, 2025 (date) — Date of earliest event reported
- May 13, 2025 (date) — Filing date
FAQ
What is the primary purpose of this 8-K/A filing?
The primary purpose is to amend a previous filing concerning the completion of an acquisition or disposition of assets and to include financial statements and exhibits related to this event.
When was the earliest event reported in this filing?
The earliest event reported was on April 15, 2025.
What was Tvardi Therapeutics, Inc. formerly known as?
Tvardi Therapeutics, Inc. was formerly known as Cara Therapeutics, Inc.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the business address of Tvardi Therapeutics, Inc.?
The business address is 3 Sugar Creek Ctr. Blvd. Suite 525, Sugar Land, Texas 77478.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on May 13, 2025 regarding Tvardi Therapeutics, Inc. (TVRD).